Latoya Stephens, MD
Obstetrics & Gynecology · Newnan, GANPI 1316106032
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $28,218 of the $37,757 with a category attached, or 74.7%. Astellas Pharma US Inc accounts for 89.5% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2023 at $27,839 and has fallen 93.6% since, to $1,773 in 2025. Among obstetrics & gynecology clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 101 payments — averaging $373.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$34K
- Intuitive Surgical$2K
- Galderma Laboratories, L.p.$431
- AbbVie$208
- Merz North America, Inc.$155
- Novo Nordisk$144
- plus $640 from 16 others
What the payments were for
- Speaking & faculty fees$28,21875%
- Travel & lodging$5,50615%
- Food & beverage$2,5337%
- Education$1,5004%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 35 | $33,802 |
| Intuitive Surgical | 9 | $2,377 |
| Galderma Laboratories, L.p. | 5 | $431 |
| AbbVie | 11 | $208 |
| Merz North America, Inc. | 3 | $155 |
| Novo Nordisk | 5 | $144 |
| Currax Pharmaceuticals LLC | 7 | $109 |
| Bayer | 4 | $78 |
| Hologic Sales And Service, LLC | 3 | $59 |
| Biogen | 2 | $56 |
| Mayne Pharma Commercial LLC | 3 | $55 |
| Sumitomo Pharma America, Inc. | 3 | $47 |
| Lupin Inc. | 2 | $32 |
| Boston Scientific | 1 | $31 |
| Myriad Women's Health, Inc. | 1 | $30 |
| Dysis Medical, Inc. | 1 | $24 |
| Astellas Pharma Global Development | 1 | $23 |
| Organon | 1 | $22 |
| Abbott | 1 | $22 |
| Evofem Biosciences, Inc. | 1 | $21 |
| Coopersurgical, Inc. | 1 | $16 |
| Mylan Pharmaceuticals Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Veozah$33,075
- DAVINCI XI$1,500
- Da Vinci Surgical System$625
How this compares
$37,757 in reported general payments places this provider in the 95th percentile of 1,324 obstetrics & gynecology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Liothyronine Sodium | 13 | $230 |
| Levothyroxine Sodium | 21 | $129 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Newnan
- Kimberly CrossNewnan$10K
- Edmund KimLawrenceville$628K
- Jacquelin WaltersDuluth$147K
- Nicole SparksJohns Creek$121K
- Lethenia BakerThomaston$111K
- Renee AllenAtlanta$74K
- Matthew RalstenFayetteville$64K
- Murray FreedmanAugusta$48K
- Tosha Rogers-JonesAtlanta$46K
- Teresa ByrdMarietta$41K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.